UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________
FORM 8-K
________________________
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 6, 2024
________________________
LKQ CORPORATION
(Exact name of registrant as specified in its charter)
_______________________
Delaware | 001-42002 | 36-4215970 | ||||||||||||||||||
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||||||||
5846 Crossings Boulevard | ||||||||||||||||||||
Antioch, Tennessee | 37013 | |||||||||||||||||||
(Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code: (615) 781-5200
N/A
(Former name or former address, if changed since last report)
________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | |||||||||||||||
Common Stock, par value $.01 per share | LKQ | The Nasdaq Global Select Market | |||||||||||||||
4.125% Notes due 2031 | LKQ31 | The Nasdaq Global Select Market |
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 7.01 | Regulation FD Disclosure. |
On September 10, 2024, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time), members of executive management of LKQ Corporation (the "Company") will host an Investor Day. The Company issued a press release on August 6, 2024 related to the Investor Day; a copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference. The Investor Day will include presentations by executive management, including a question and answer session.
The webcast and accompanying slide presentation will be available in the Investor Relations section of the Company's website, www.lkqcorp.com, on September 10, 2024. An online replay of the webcast will be available on the Company's website by the day after the live presentation.
The information in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, (the "Exchange Act"), nor shall it be incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit Number | Description of Exhibit | |||||||
LKQ Corporation Press Release dated August 6, 2024. | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 6, 2024
LKQ CORPORATION | |||||
By: | /s/ Rick Galloway | ||||
Rick Galloway | |||||
Senior Vice President and Chief Financial Officer |